Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
445.03
-8.77 (-1.93%)
Sep 9, 2025, 10:24 AM - Market open

Madrigal Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
9,9196,7304,5685,1791,4491,719
Upgrade
Market Cap Growth
12.54%47.33%-11.79%257.45%-15.74%22.31%
Upgrade
Enterprise Value
9,4425,8514,4525,0751,1511,384
Upgrade
Last Close Price
453.80308.57231.38290.2584.74111.17
Upgrade
PS Ratio
19.3637.36----
Upgrade
PB Ratio
14.498.9211.2726.247.397.17
Upgrade
P/TBV Ratio
14.638.9811.2726.247.397.17
Upgrade
EV/Sales Ratio
18.3132.48----
Upgrade
Debt / Equity Ratio
0.180.160.290.250.000.00
Upgrade
Asset Turnover
0.490.21----
Upgrade
Quick Ratio
4.465.795.353.103.526.10
Upgrade
Current Ratio
5.116.105.383.123.546.13
Upgrade
Return on Equity (ROE)
-36.30%-80.35%-123.98%-150.12%-110.92%-61.61%
Upgrade
Return on Assets (ROA)
-18.31%-36.98%-47.41%-57.71%-54.09%-35.44%
Upgrade
Return on Capital (ROIC)
-21.57%-44.56%-61.78%-82.62%-69.25%-39.26%
Upgrade
Earnings Yield
-2.79%-6.92%-8.18%-5.70%-16.69%-11.76%
Upgrade
FCF Yield
-3.05%-6.79%-7.13%-4.35%-12.71%-9.18%
Upgrade
Buyback Yield / Dilution
-10.46%-13.83%-9.05%-3.64%-7.05%-0.34%
Upgrade
Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q